Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

IFRX stock hub

InflaRx N.V. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

IFRXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

186.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

IFRX

In the news

Latest news · IFRX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-79.9

P25 -105.6P50 -46.5P75 -3.1

ROIC-48.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All IFRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

199

Groups with data

Currency

EUR

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001708688
Company name	InflaRx N.V.
Country	Germany
Country code	US
Cusip	N44821101
Employees	65
Employees Change	-9%
Employees Change Percent	-12.16
Enterprise value	$141.6M
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2017-11-08
Isin	NL0012661870
Last refreshed	2026-05-10
Market cap	$186.5M
Market cap category	Micro-Cap
Price	$2.58
Price currency	USD
Rev Per Employee	520.29x
Sector	Healthcare
Sic	2834
Symbol	IFRX
Website	https://www.inflarx.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-26.53%
EV Sales Forward	9,679.1x
EV/Sales	4,186.23x
FCF yield	-18.21%
P/B ratio	4.39x
P/S ratio	5,515.11x
PS Forward	12,751.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-8.3M
Net Income	$-49.5M
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Pretax Margin	-146,260.95%
Profit Per Employee	$-761,202
ROA	-39.06
Roa5y	-31.59
ROCE	-113.2
ROE	-79.94
Roe5y	-53.96
ROIC	-48.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	73.22%
Cagr3y	-16.17%
Cagr5y	-6.55%
EPS Growth Quarters	1
EPS Growth Years	1
Revenue Growth	-77.4x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$56.4M
Cash	$45.9M
Current Assets	$55.9M
Current Liabilities	$13.4M
Debt	$948,954
Debt Equity	$0.02
Equity	$42.5M
Interest Coverage	-849.9
Liabilities	$13.8M
Long Term Assets	$474,208
Long Term Liabilities	$402,213
Net Cash	$44.9M
Net Cash By Market Cap	$24.1
Net Cash Growth	-40.18%
Net Debt Equity	$-1.06
Tangible Book Value	$42.5M
Tangible Book Value Per Share	$0.59
WACC	17.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.16
Net Working Capital	$-4.1M
Quick ratio	3.64
Working Capital	$41.5M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-15.84%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	73.15%
200-day SMA	1.17
3Y total return	-41.1%
50-day SMA	1.27
50-day SMA vs 200-day SMA	50over200
5Y total return	-28.73%
All Time High	53.1
All Time High Change	-95.14%
All Time High Date	2019-04-24
All Time Low	0.71
All Time Low Change	262.72%
All Time Low Date	2025-05-28
ATR	0.28
Beta	2.44
Beta1y	1.87
Beta2y	1.66
Ch YTD	155.4
High	2.8
High52	2.95
High52 Date	2026-05-07
High52ch	-12.51%
Low	2.36
Low52	0.71
Low52 Date	2025-05-28
Low52ch	262.72%
Ma50ch	102.83%
Premarket Change Percent	-1.89
Premarket Price	$2.6
Premarket Volume	18,959
Price vs 200-day SMA	120.89%
RSI	78.22
RSI Monthly	58.87
RSI Weekly	79.06
Sharpe ratio	1.11x
Sortino ratio	1.71
Total Return	-15.84%
Tr YTD	155.4
Tr1m	166.75%
Tr1w	22.86%
Tr3m	188.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	3
Analyst Price Target Top	$6.33
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.17
Earnings Revenue Estimate	10,000x
Operating Income	$-49M
Operating margin	-144,768.7
Price target	$6.25
Price Target Change	$142
Price Target Change Top	$145

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	60,014,330%
Float Percent	83.02%
Net Borrowing	-391,734.5
Shares Insiders	6.01%
Shares Institutions	16%
Shares Out	72,292,859
Shares Qo Q	2.84%
Shares Yo Y	15.84%
Short Ratio	3.09
Short Shares	3.01

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-37.3M
Average Volume	3,275,005.65x
Bv Per Share	0.59
CAPEX	$-132,267
Ch1m	166.7
Ch1w	22.86
Ch1y	73.15
Ch3m	188.3
Ch3y	-41.1
Ch5y	-28.73
Ch6m	109.8
Change	-2.64%
Change From Open	-1.53
Close	2.65
Days Gap	-1.13
Depreciation Amortization	40,789.6
Dollar Volume	19,319,455.4
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$-49M
EBITDA	$-48.9M
EPS	$-0.71
F Score	1
FCF	$-34M
FCF EV Yield	-23.99x
FCF Per Share	$-0.47
Financing CF	7,186,044
Fiscal Year End	December
Founded	2,007
Income Tax	$14,161
Investing CF	-9,551,602
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-20
Ma150	1.18
Ma150ch	119.2%
Ma20	1.78
Ma20ch	45.35%
Net CF	-37,233,758
Next Earnings Date	2026-08-06
Open	2.62
Optionable	Yes
Position In Range	50
Post Close	2.58
Postmarket Change Percent	-0.39
Postmarket Price	$2.57
Ppne	1,261,787.7
Pre Close	2.65
Price Date	2026-05-08
Ptbv Ratio	4.39
Relative Volume	2.29x
Revenue	33,819x
SBC By Revenue	9,906.61x
Share Based Comp	3,350,317
Tax By Revenue	41.87x
Tr6m	109.76%
Volume	7,488,161

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does IFRX pay a dividend?

Capital-return profile for this ticker.

Performance

IFRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns IFRX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.0%

Float: +83.0% of shares outstanding

Insider ownership

+6.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

IFRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

78.2

Above 70: short-term overbought

Price vs 200-day MA

+120.9%

50/200-day relationship not available

Beta (5Y)

2.44

More volatile than the market

Sharpe ratio

1.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About IFRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current IFRX stock rating?

InflaRx N.V. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full IFRX analysis?

The full report lives at /stocks/IFRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for IFRX?

The latest report frames IFRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the IFRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.